A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer - NCT00642018-38138 (Clinical Trial 210888)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy210888.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Memphis |
|
State:
|
|
TN |
| Zip Code: |
|
38138 |
| Conditions: |
|
Prostate Cancer |
| Purpose: |
|
The primary purpose of this study is to determine whether LY2181308 in combination with
docetaxel is safe and effective treatment for hormone refractory prostate cancer patients.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Histologically or cytologically confirmed adenocarcinoma of the prostate which is
metastatic and/or unresectable
- Hormone refractory prostate cancer defined as progressive based by documented 2
increase PSA values over a previous reference value.
- ECOG status 0-2
- Adequate hematological functions, liver and renal functions
Exclusion Criteria:
- Known hypersensitivity to docetaxel or taxane therapy
- Documented central nervous system or leptomeningeal metastasis at time of study entry
- Had prior treatment with chemotherapy, bone seeking radionucleides in past 6 weeks
prior to enrollment, or radiotherapy involving more than 25% of marrow producing
area.
- Evidence of painful and/or destructive bone metastases for which radiation therapy,
biophosphonates or boneseeking radionucleides are necessary.
- Have received treatment in the last 30 day with a drug which has not received
regulatory approval for any indication at the time of study entry. |
|
|
|
| Study is available at: |
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Memphis, TN 38138
United States
Primary Contact:
There may be multiple sites in this clinical trial 1-877-CTLILLY (1-877-285-4559)
Phone: 1-317-615-4559 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|